Document is current
Any future updates will be listed below
-
Authors
Nakamura, Toshinori
Furihata, Ryuji
Hasegawa, Naomi
Kodaka, Fumitoshi
Muraoka, Hiroyuki
Ichihashi, Kayo
Ochi, Shinichiro
Numata, Shusuke
Tsuboi, Takashi
Makinodan, Manabu
Iida, Hitoshi
Onitsuka, Toshiaki
Kashiwagi, Hiroko
Takeshima, Masahiro
Hashimoto, Naoki
Nagasawa, Tatsuya
Usami, Masahide
Yamagata, Hirotaka
Takaesu, Yoshikazu
Miura, Kenichiro
Matsumoto, Junya
Ohi, Kazutaka
Yamada, Hisashi
Hori, Hikaru
Inada, Ken
Watanabe, Koichiro
Hashimoto, Ryota
Yasui-Furukori, Norio
-
Funding
Funding for this research was provided by:
the Japanese Society of Neuropsychopharmacology
the Japanese Society of Mood Disorders
the Japanese Society of Clinical Neuro-psycho-pharmacology
Japan Agency for Medical Research and Development (JP19dk0307083, JP22dk0307112, JP19dk0307083, JP22dk0307112, JP19dk0307083, JP22dk0307112, JP19dk0307083, JP22dk0307112, JP19dk0307083, JP19dk0307083, JP22dk0307112, JP19dk0307083, JP19dk0307083, JP19dk0307083, JP16dk0307060, JP19dk0307083, JP19dk0307083)
JSPS KAKENHI (JP21K17261)
the Health and Labor Sciences Research Grants (19GC1201, 19GC1201, 19GC1201)
- License Information
-
More Information
Article History
Received: 20 March 2024
Accepted: 5 May 2024
First Online: 29 May 2024
Declarations
:
: The study was approved by the Ethics Committee of the National Center of Neurology and Psychiatry and each participating institution. Written informed consent was obtained from all participants before participation in the EGUIDE project. Opt-outs were granted, and patient medical record information was collected at each facility participating in the EGUIDE project. The protocol of the EGUIDE project is registered with the University Hospital Medical Information Network Center (UMIN000022645).
: Not applicable.
: The authors declare no competing interests.
